Collecting data on the safety and performance of TEKNIMED bone substitutes
Official title: Safety and Clinical Performance Assessment of Bone Substitutes Used for Bone Voids Filling - A Post-Market Clinical Follow-Up
Run by Teknimed · NCT06374342 · Data updated 2026-11-12
This study is testing how safe and effective TEKNIMED's bone substitutes are for patients who have had surgeries that needed these products.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 425 (estimated) |
| Sponsor | Teknimed Industry-sponsored |
| Locations | 6 sites (Mainvilliers, Eure et Loir and 5 other locations) |
| Status | Recruiting |
| Started | September 16, 2021 |
| Main results expected | September 16, 2026 |
| Study ends | September 30, 2032 |
| Registry record updated | September 9, 2025 |
| Trial ID | NCT06374342 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are undergoing surgery requiring bone filling with TEKNIMED substitutes.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or under legal guardianship will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather clinical data on the safety and performance of TEKNIMED's range of bone substitutes, including CERAFORM, TRIHA+, and NANOGEL. It involves both retrospective and prospective data collection from patients who have undergone surgeries requiring these products. The study will follow patients according to local standard medical care, assessing the effectiveness of these synthetic alternatives to traditional bone grafts. The goal is to confirm the safety and efficacy of these products in real-life clinical settings.
Why it matters
Potential benefit: If successful, this study could provide valuable evidence supporting the use of TEKNIMED bone substitutes, potentially improving patient outcomes in bone defect surgeries.
How similar studies have gone: Previous studies have demonstrated the safety and efficacy of synthetic bone substitutes, making this approach consistent with established findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be 18 years or older. * Be willing to sign an informed consent approved by IRB or EC (where applicable) or not being opposed to the use of their clinical data in the study (France) and o For prospective inclusion: * Be considered for a surgery where bone filling with one of the TEKNIMED bone substitutes comprised in this study is needed and intended to be used according to the IFU. o For retrospective inclusion: * Have undergone a surgery with a TEKNIMED bone substitute used according to the IFU, between the 1st January 2015 and the date of the site initiation visit * Be informed of the study and not being opposed to the use of their clinical data in the study (France) or be willing to sign an informed consent (where applicable) during the first follow-up visit following the site initiation. Exclusion Criteria: Patients presenting one of the following conditions will not be included: * Under trusteeship or guardianship * Pregnancy or breast-feeding women According to contraindications per IFU: * Procedures other than those stated in the INDICATIONS section * Patients susceptible to allergic reactions to the product components. CERAFORM®, TRIHA+®: \- Treatment of large bone defects which could impact the stability of bone structure without implementing a mechanical stabilisation system (such as plate(s), screw(s), nail(s), cage(s)) NANOGEL®: * Use in vertebroplasty procedures * Subcutaneous use
Where it's running
-
Pôle Rachis Hôpital Privé d'Eure et Loir
Mainvilliers, Eure et Loir, France Recruiting -
Hôpital Joseph Ducuing
Toulouse, Haute Garonne, France Recruiting -
Clinique Médipole Garonne
Toulouse, Haute Garonne, France Recruiting -
CHRU Brabois
Nancy, Meurthe et Moselle, France Recruiting -
Clinique du Pré
Le Mans, Sarthe, France Recruiting -
OCM Klinik GmbH
München, Bavaria, Germany Recruiting
Study contacts
- Study coordinator: Solange VAN DE MOORTELE, PhD
- Email: s.vandemoortele@teknimed.com
- Phone: +33534252679
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
UV-treated dental implants with or without melatonin in the upper back jaw
This study tests whether UV-treated implants alone or with melatonin help regenerate bone and strengthen implants in the upper back jaw.
-
Single-surgery Bone Ring Technique for Sinus Lift and Dental Implant in the Back of the Upper Jaw
This study tests a one-step Bone Ring Technique to lift the sinus and place a dental implant in patients with very thin upper jaw bone.
-
Immediate implant with bone and connective tissue grafting for upper front teeth
This study will test whether flapless guided immediate implants with socket grafting, a connective tissue graft, and an immediate provisional crown work well for adults who need an upper front tooth removed.
-
Bone grafting beyond the original bone line for dental implants
A study tests whether adding a bit more bone beyond the natural shape improves implant outcomes compared with stopping at the original bone line.
-
Three soft-tissue methods for single immediate implants in the upper front teeth
This will see which of three soft-tissue grafting methods best prevents buccal gum loss for adults receiving a single immediate implant in the upper front teeth.
-
Comparing two techniques for placing dental implants
This study is testing two different methods for placing dental implants to see which one works better for people with missing teeth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.